Objectives-To evaluate the therapeutic effect from ultrasound in the treatment of plantar heel pain by physiotherapists and podiatrists, and to quantify the placebo effect of this electrophysical agent. Methods-Patients experiencing episodes of plantar heel pain were allocated ran-
there was a clear need to evaluate ultrasound treatment, by means of a double blind trial aiming to establish if treatment is more effective than placebo. This study recorded pain scores before and after true or sham ultrasound treatment of 26 episodes of localised heel pain unassociated with systemic inflammatory disease.
Patients and methods Patients were selected from those attending The London Foot Hospital who were referred for the management of their heel pain by general practitioners, rheumatologists, and physiotherapists. The criterion for inclusion in the study was pain on the plantar aspect of one or both heels. Exclusion criteria were: previous treatment with ultrasound; presence of fluffy calcaneal spur on radiograph; generalised joint pain; non-specific urethritis; the use of pain control (analgesics, non-steroidal antiinflammatory drugs (NSAIDs), steroids, heel pads or orthoses/appliances in shoe(s)) at the time of recruitment; a diagnosis of a seropositive or seronegative arthropathy.
Patients were requested to avoid the use of pain controlling methods for the duration of the trial in order to 3 MHz, and pulsed 1:4, twice weekly for four weeks; painful heels in the placebo group received a sham dose of ultrasound, only the timer on the machine being activated for eight minutes. In both groups treatments were given using a Sonacel Mutiphron Mk II ultrasound machine. All treatments were given using a coupling gel.
Pain was assessed using a 10 cm horizontal visual analogue scale at the first and last visit. The patients' final pain score(s) were made without reference to their initial pain scores. An independent observer (SDJ) set the dosage on the machine in accordance with the randomly assigned treatment group, before covering the dials with a drape to obscure them from both the operator and the patient. Treatment was given and pain scores recorded by one operator blinded to the treatment group (true or sham) throughout the trial (FC). The ultrasound machine was regularly checked during the trial by the medical physics department of The Middlesex Hospital, to ensure it was calibrated correctly. A power equation indicated that 26 results would detect an improvement of 50% or greater. Taking 20% as a placebo response, such numbers would therefore detect an improvement of 30% over placebo. Statistics were performed using Wilcoxon signed-ranks test and Fisher's exact test.
Results
Nineteen patients with 26 episodes of heel pain (seven bilateral) entered the study. Of the seven patients with bilateral disease, only one received identical randomisation (placebo) to both feet. There were thus six women (three with bilateral disease episodes) and seven men (three with bilateral disease episodes) who received true ultrasound, and five women (three with bilateral episodes) and eight men (five with bilateral episodes) who received placebo treatment. In the treatment group, the median duration of pain was 12 months; in the placebo group it was 24 months. In accordance with our selection criteria, none of the 19 patients recruited was taking NSAIDs or analgesics at the commencement of the study or at any time thereafter: this is reflective of patients attending a podiatry outpatient clinic, whose use of NSAID analgesics is much less widespread than that of rheumatology outpatients. Seven patients (two with bilateral disease) had received corticosteroid injections which had not produced relief: two episodes in the true ultrasound group (one bilateral disease episode), and five episodes in the placebo group (one bilateral disease episode). Figure 1 shows the pain scores recorded before and after each complete course of ultrasound. Both groups showed a reduction in pain: the mean pain score before treatment in the treated group was 6x7, which reduced to 4-5 after treatment (mean improvement 30%); the placebo group had a mean pain score of 7-5 before treatment, which reduced to 5-6 (mean improvement 25%). This difference in improvement was not statistically significant (Wilcoxon signed-ranks test). There was no significant difference between pain duration and improvement (Fisher's exact test) in either group, and no significant difference between age of the patient and improvement (Fisher's exact test) in either group. In 21 episodes of heel pain, a positive Helbing's sign (lateral bowing of the tendo Achillis) was observed, and in 12 episodes there was radiographic evidence of a well corticated calcaneal spur; no statistical relationship existed between these two factors (Fisher's exact test). Complete resolution of pain did not occur in any episode, and pain worsened during the study in four episodes: two in the treatment group and two in the placebo group. Pain neither improved nor worsened in two episodes: one in the treatment group and one in the placebo group.
Discussion
The chronic nature of the painful heels in the trial accurately represents the population seeking treatment from The London Foot Hospital, a tertiary referral centre. Plantar fasciitis is the most common diagnosis given to pain on the plantar aspect of the heel. This term oversimplifies the painful heel, which may have one of several aetiologies,21 explanations of which are outside the remit of this paper. The aetiology of plantar heel pain is believed to be associated with lower limb biomechanics-that is, pronation producing tension on the soft tissues of the plantar surface-or part of a systemic inflammatory condition. Patients who presented with likely signs of systemic inflammatory disease related heel pain were excluded from the trial in an effort to assess the ultrasound treatment with minimal variables. There is some debate as to whether excessive subtalar joint pronation is related to both heel pain and calcaneal spur formation.19 22 23 Our finding of no statistically significant relationship between the presence of heel spur and Helbing's sign in the patients participating in this study adds to that debate, and further work is required to define the relationship between subtalar joint pronation, heel pain, and calcaneal spur formation. We acknowledge that, while Helbing's sign may indicate excessive subtalar joint pronation, bowing of the tendo Achillis may apparently be absent when the subtalar joint is actually pronated. As yet, no error free method of measuring subtalar joint pronation is available.
The selection of the dose of ultrasound was based on the clinical judgment of the authors and reached in consultation with physiotherapy colleagues. The intensity of 0 
